Virus, radiation & drugs team up to fight tough liver tumors
NCT ID NCT07381309
Summary
This study is testing a combination of treatments for colorectal cancer that has spread to the liver and cannot be removed by surgery. The main new part is an injection of a specially engineered virus (H101) around the tumor, which is designed to attack cancer cells. This virus injection is given along with targeted radiation, immunotherapy, chemotherapy, and targeted drugs. The goal is to see if this multi-pronged attack can shrink tumors better than current options for this hard-to-treat cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASIS COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sixth Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.